C000220956 Performance — BlackRock LifePath ESG Index 2060 Fund, Institutional Class
Data updated: 2026-09-25
C000220956 returned +11.80% year to date and +22.53% over one year to Jul 2026. Annualised returns are +17.36% over 3 years and +9.95% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $162, against $146 for the category, and to $123 over one year, against $116. Volatility over the past three years was 12.47% a year. In the 12 months to Jul 2026 the fund took in a net $4.1M, and assets reached $19.16M.
C000220956 Growth of $100
What $100 invested in BlackRock LifePath ESG Index 2060 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | C000220956 | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $123 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $162 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $161 | $142 |
| Since data start (Aug 2020 – Jul 2026) | $210 | $174 |
C000220956 Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.80% |
| 1 year | +22.53% |
| 3 years (annualised) | +17.36% |
| 5 years (annualised) | +9.95% |
C000220956 Annual Returns
Calendar-year total returns of BlackRock LifePath ESG Index 2060 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +11.80% |
| 2025 | +20.87% |
| 2024 | +15.62% |
| 2023 | +21.18% |
| 2022 | −18.66% |
| 2021 | +19.93% |
| 2020 (Aug–Dec) | +13.75% |
C000220956 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.2% | +1.7% | −6.4% | +9.3% | +4.4% | +0.1% | −0.4% | — | — | — | — | — |
| 2025 | +2.9% | −0.6% | −3.6% | +0.4% | +5.7% | +4.6% | +0.7% | +3.0% | +3.3% | +1.9% | +0.2% | +0.9% |
| 2024 | −0.2% | +4.0% | +3.2% | −3.7% | +4.4% | +1.8% | +2.4% | +2.4% | +2.4% | −2.5% | +4.2% | −3.1% |
| 2023 | +7.8% | −3.0% | +2.3% | +1.4% | −1.3% | +5.5% | +3.6% | −2.9% | −4.5% | −3.0% | +9.1% | +5.4% |
| 2022 | −4.9% | −3.0% | +2.1% | −8.0% | +0.2% | −8.5% | +7.6% | −4.6% | −9.7% | +6.7% | +8.2% | −4.4% |
| 2021 | −0.3% | +2.9% | +3.3% | +4.1% | +2.0% | +1.0% | +1.1% | +2.3% | −4.1% | +5.3% | −2.9% | +4.0% |
| 2020 | — | — | — | — | — | — | — | +1.6% | −3.1% | −2.2% | +12.9% | +4.7% |
C000220956 Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 12.47%
- 3-year Sharpe ratio: 1.03 (vs 4.5% risk-free rate)
- Best month: +9.34% (Apr 2026)
- Worst month: −6.36% (Mar 2026)
C000220956 Fund Flows
Monthly money in and out of BlackRock LifePath ESG Index 2060 Fund, from SEC Form N-PORT.
- 12-month net flow: $4.1M
- 12-month gross sales (incl. reinvestments): $6.3M
- Sales ÷ redemptions: 2.84×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $326K | $118K | $208K |
| Jun 2026 | $1.8M | $272K | $1.5M |
| May 2026 | $524K | $386K | $138K |
| Apr 2026 | $465K | $225K | $240K |
| Mar 2026 | $284K | $163K | $120K |
| Feb 2026 | $429K | $131K | $298K |
| Jan 2026 | $234K | $69K | $165K |
| Dec 2025 | $561K | $205K | $356K |
| Nov 2025 | $214K | $180K | $34K |
| Oct 2025 | $625K | $189K | $437K |
| Sep 2025 | $258K | $171K | $87K |
| Aug 2025 | $571K | $96K | $474K |
C000220956 Assets Under Management
Net assets of BlackRock LifePath ESG Index 2060 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $19.16M |
| 2026-04-30 | $16.65M |
| 2026-01-31 | $15.32M |
| 2025-10-31 | $14.38M |
| 2025-07-31 | $12.30M |
| 2025-04-30 | $6.79M |
| 2025-01-31 | $6.96M |
| 2024-10-31 | $5.98M |
| 2024-07-31 | $5.83M |
| 2024-04-30 | $5.22M |
| 2024-01-31 | $4.89M |
| 2023-10-31 | $3.82M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.